Evidence Synthesis

Expert-led, technology-enhanced evidence synthesis

Evidence synthesis is foundational to healthcare decision-making and product development. Our dedicated evidence synthesis teams, supported by advanced technology, provide an agile, dynamic, and impactful solution.

Our biopharma evidence synthesis services include:

Systematic literature reviews (SLRs)
Targeted literature reviews (TLRs)
Landscape reviews
Evidence mapping

Meta-analyses
Meta-regression
Indirect treatment comparisons, including NMA and MAIC
Simulated treatment comparisons

Leverage the evidence base

Our multidisciplinary evidence synthesis teams offer expertise across RWE, HEOR, biostatistics, and access and pricing, providing the evidence you need within the most demanding of timelines and allowing you to focus on strategic interpretation.

We provide qualitative and quantitative evidence synthesis to support varying requirements, including dossier development, internal strategy support, gap analysis, modelling inputs, publication, HTA/payer/reimbursement submissions, regulatory submissions, rapid reviews, and more.

Ongoing reviews for competitor intelligence: Efficient regular updates to keep you ahead of the emerging evidence base.
Rapid turnarounds: Answering urgent scientific questions within hours, and meeting the tightest of deadlines (e.g. mid-appraisal rejections).
Enhanced evidence synthesis: Faster and more comprehensive systematic/targeted literature reviews, landscape analysis, and regulatory and HTA response generation.

Ask us about evidence synthesis

EVID AI

Faster, transparent, high-quality systematic reviews

Our dedicated evidence synthesis teams are supported by EVID AI, an AI-powered online database of literature-based evidence which employs semantic understanding to extract transparent and exportable data from published literature and identifies the context from which it has been extracted.

How does it work?

100m

data points of evidence curated

56

faster than human searches using PubMed

15

more articles found and 15x fewer irrelevant ones

Flexible Integrated Teams (FIT)

Making fit-for-purpose expertise the new standard: Our team becomes your team

Our biopharma evidence synthesis services can be offered as part of an optional FIT engagement. These flexible partnerships provides dedicated, cross-functional teams that integrate seamlessly within your own to fill experience gaps or supplement existing resources.

The size and composition of your team can gradually evolve or pivot quickly to meet your changing needs, all without the costly delays involved in adjusting a statement of work.

A trusted extension of your organization, our team becomes your team.

Learn more

Evidence Synthesis Case Study

Targeted literature review for lung cancer RWE to support HTA submission

There was a lack of literature and randomized controlled trial data evaluating to the post-surgery follow-up care among early non-small cell lung cancer (eNSCLC) patients who experienced locoregional recurrence. Client required literature review expertise to assess current state of the eNSCLC outcomes.

Genesis Research Group collaborated with the client to design and conduct a targeted literature review (TLR) to analyze survival and treatment patterns outcomes in observational studies.

Ultimately, the data found was used to support inputs for economic models and health technology assessment (HTA) submission.

Download full case study

Genesis Research Hub

Publications

Explore our publications for details of our peer-reviewed research and therapeutic experience.

Insights

Delve deeper into Genesis Research: videos, interviews, papers, webinars, and case studies.

News & Events

Check out our latest news and events. We hope to see you soon at an upcoming show or webinar!

Case studies

How our approach, expertise, and research capabilities have impacted upon our clients' success.

Keep current on the latest research and learn more about our work by signing up to our newsletter.